For some applications – such as in developmental biology – the genome cannot just be chopped up into tiny pieces before decoding. Instead, long read lengths of several thousand bases are needed. A recent paper in Nature shows what the PacBio sequencer at the Scientific Genomics Platform at the MDC can do.
MDC and BIH erect a new research facility for physicians, researchers and patients. The Käthe Beutler building will be completed in 2020.
On this day 25 years ago, the MDC was officially named after the geneticist Max Delbrück. Many things have changed since then. The MDC’s Director Martin Lohse looks forward into the future: What will the research center look like in 2042?
Prof. Martin Lohse is the Chairman of the Board of Directors and Scientific Director of the MDC since April 2016. He talks about his plans for the research center in an interview with the capus magazine buch inside, reproduced below.
Mass spectrometry metabolomics at the MDC now has a second leg to stand on: On October 1, Dr. Jennifer Kirwan took up her position as the new head of the Metabolomics Core Facility of the Berlin Institute of Health (BIH), which is situated at the MDC. Dr. Stefan Kempa, who has been in charge until now, will continue to head the Metabolomics Core Facility within BIMSB.
In cancer, one of the body’s cells stops playing by the rules that govern the cell cycle and divides uncontrollably. This is often due to mutations that lead to errors in the mechanisms that control cell division. Several teams of scientists at the MDC and the Charité are working on a T-cell therapy that specifically […]
A joint press release by the Max Delbrück Center for Molecular Medicine (MDC), Charité – Universitätsmedizin Berlin, and the Berlin Institute of Health (BIH) From 2017, a new building will be constructed on the Berlin-Buch research campus that will unite several institutions under one roof. The Max Delbrück Center for Molecular Medicine (MDC) and Charité […]
An international research team from the Max Delbrück Center for Molecular Medicine (MDC) and the Charité (partners in the Berlin Institute of Health, BIH), the Humboldt University Berlin and the University of Chicago has successfully modified immune cells to recognize and specifically target tumor cells in mice. Cancer treatments based on the findings would likely […]
A search for new junior group leaders for BIH and IRI
While progress has surely been made in recent years, we all know that there remain some important barriers to full gender equality in science and many other fields. It’s not enough to change minds alone: traces of old habits linger in educational systems and institutions. The best way to expose gender issues – which are […]